The tissue-specific expression of lipoprotein lipase: Implications for energy and lipoprotein metabolism

Current Opinion in Lipidology

Volumn 8, Issue 2, 1997, Pages 77-88

  Zechner, Rudolf ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; LIPOPROTEIN; LIPOPROTEIN LIPASE; MUSCLE ENZYME; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROGENESIS; BODY WEIGHT; DRUG DISTRIBUTION; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME REGULATION; HOMEOSTASIS; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPOPROTEIN METABOLISM; MACROPHAGE; MUSCLE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE SPECIFICITY;

ANIMALS; ENERGY METABOLISM; GENE EXPRESSION; HUMANS; LIPOPROTEIN LIPASE; LIPOPROTEINS; MICE; ORGAN SPECIFICITY;

EID: 0031007874     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199704000-00005     Document Type: Review

References (174)

1. Olivecrona T, Bengtsson-Olivecrona G: Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol 1993, 4:187-196.
2. Enerback S, Gimble JM: Lipoprotein lipase gene expression: physiological regulators at the transcriptional and post-transcriptional level. Biochim Biophys Acta 1993, 1169:107-125.
3. Santamarina-Fojo S, Dugi KA: Structure, function and role of lipoprotein lipase in lipoprotein metabolism. Curr Opin Lipidol 1994, 5:117-125.
4. Olivecrona G, Olivecrona T: Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 1995, 6:291-305.
5. Goldberg IJ: Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996, 37:693-707.
6. Beisiegel U: New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis. Atherosclerosis 1996, 124:1-8.
7. Skottova N, Savonen R, Lookene A, Hultin M, Olivecrona G: Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver. J Lipid Res 1995, 36:1334-1344.
8. Olivecrona T, Bergö M, Hultin M, Olivecrona G: Nutritional regulation of lipoprotein lipase. Can J Cardiol 1995, Suppl G:73G-78G.
9. Semb H, Olivecrona T: Two different mechanisms are involved in nutritional regulation of lipoprotein lipase in guinea-pig adipose tissue. Biochem J 1989, 262:505-511.
10. Doolittle MH, Ben-Zeev O, Elovson J, Martin D, Kirchgessner TG: The response of lipoprotein lipase to feeding and fasting. Evidence for posttranslational regulation. J Biol Chem 1990, 265:4570-4577.
11. Braun JEA, Severson DL: Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochem J 1992, 287:337-347.
12. Carroll R, Liu L, Severson DL: Post-transcriptlonal mechanisms are responsible for the reduction in lipoprotien lipase activity in cardiomyocytes from diabetic rat hearts. Biochem J 1995, 310:67-72.
13. Fernandez ML, Conde AK, Ruiz LR, Montano C, Ebner J, McNamara DJ: Carbohydrate type and amount alter intravascular processing and catabolism of plasma lipoproteins in guinea pigs. Lipids 1995, 30:619-626.
14. Bergö M, Olivecrona G, Olivecrona T: Forms of lipoprotein lipase in rat tissues: In adipose tissue the proportion of inactive lipase increases on fasting. Biochem J 1996, 313:893-898.
15. Semenkovich CF, Wimst M, Noe L, Etienne J, Chan L: Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J Biol Chem 1989, 264:9030-9038.
16. Raynolds MV, Awald PD, Gordon DF, Gutierrez-Hartmann A, Rule DC, Wood WM, Eckel RH: Lipoprotein lipase gene expression in rat adipocytes is regulated by isoproterenol and insulin through different mechanisms. Mol Endocrinol 1990, 4:1416-1422.
17. Coppack SW, Evans RD, Fisher RM, Frayn KN, Gibbons GF, Humphreys SM, Kirk ML, Potts JL, Hockaday TDR: Adipose tissue metabolism in obesity: Lipase action in vivo before and after a mixed meal. Metabolism 1992, 41:264-272.
18. Jeppesen J, Hollenbeck CB, Zhou MY, Coulston AM, Jones C, Chen YD, Reaven GM: Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol 1935, 15:320-324.
19. Eckel RH, Yost TJ, Jensen DR: Alterations in lipoprotein lipase in iInsulin resistance. Int J Obesity 1995, 19(suppl. 1):S16-S21.
20. Potts JL, Coppack SW, Fisher RM, Humphreys SM, Gibbons GF, Frayn KN: Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects. Am J Physiol 1995, 268:E588-E594.
21. Yost TJ, Sadur CN, Eckel RH: Glycohemoglobin levels relate to the response of adipose tissue lipoprotein lipase to insulin/glucose in obese noninsulin-dependent diabetes mellitus. Metabolism 1995, 44:1475-1780.
22. Laville M, Auboeuf D, Khalfallah Y, Vega N, Riou JP, Vidal H: Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle. J Clin Invest 1996, 98:43-49.
23. Yost TJ, Froyd K, Jensen DR, Eckel R: Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus. Metab 1995, 44:786-790.
24. Amri EZ, Teboul L, Vannier C, Grimaldi P-A, Ailhaud G: Fatty acids regulate the expression of lipoprotein lipase gene and activity in preadipose and adipose cells. Biochem J 1996, 314:541-546.
25. Eckel RH: Adipose tissue lipoprotein lipase. In Lipoprotem lipase. Edited by Borensztajn J. Chicago: Evener; 1987:79-132.
26. Borensztajn J: Heart and skeletal muscle lipoproteln lipase. In Lipoprotein lipase. Edited by Borensztajn J. Chicago: Evener; 1987:133-148.
27. Oscarsson J, Ottosson M, Johansson JO, Wiklund O, Mann P, Bjorntorp P, Bengtsson BA: Two weeks of dally injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity. Metabolism 1996, 45:370-377.
28. Brinton EA: Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 1996, 16:431-440.
29. Ottosson M, Marin P, Karason K, Elander A, Bjorntorp P: Blockade of the glucocorticoid receptor with RU 486: effects in vitro and in vivo on human adipose tissue lipoprotein lipase activity. Obes Res 1995, 3:233-240.
30. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall S: Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995, 8:894-901.
31. Vu D, Ong JM, Clemens TL, Kern PA: Dihydroxyvitamin D induced lipoprotein lipase in 3T3-L1 cells in association with adipocyte differentiation. Endocrinology 1996, 137:1540-1544.
32. Bagby GJ, Pekala PH: Lipoprotein lipase in trauma and sepsis. In Lipoprotein lipase. Edited by Borensztajn J. Chicago: Evener; 1987:247-275.
33. Price SR, Olivecrona T, Pekala PH: Regulation of lipoprotein lipase synthesis in 3T3-L1 adipocytes by cachectin. Further proof for identity with tumour necrosis factor. Biochem J 1986, 240:601-604.
34. Semb H, Peterson J, Tavernier J, Olivecrona T: Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 1987, 262:8390-8394.
35. Hülsmann WC, Dubelaar M-L, De Wit LEA, Persoon NLM: Cardiac lipoprotein lipase: effects of lipopolysaccharide and tumor necrosis factor. Mol Cell Biol 1988, 79:137-145.
36. Zechner R, Newman TC, Sherry B, Cerami A, Breslow JL: Recombinant human cachectin/tumor necrosis factor but not interteukln-1a downregulates lipoprotein lipase gene expression at the transcriptional level in mouse 3T3-L1 adipocytes. Mol Cell Biol 1988, 8:2394-2401.
37. Fried SK, Zechner R: Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. J Lipid Res 1989, 30:1917-1923.
38. Chajek-Shaul, Friedman G, Stein O, Shiloni E, Etienne J, Stein Y: Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to rats. Biochim Biophys Acta 1989, 316-324.
39. Kern PA: Recombinant human tumor necrosis factor does not inhibit lipoprotein lipase in primary cultures of isolated human. J Lipid Res 1988, 29:909-914.
40. Grunfeld C, Gulli R, Moser AH, Gavin LA, Feingold KR: Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res 1989, 30:579-585.
41. Morin CL, Schlaepfer IR, Eckel RH: Tumor necrosis factor-α eliminates binding of NF-Y and an octamer-binding protein to the lipoprotein lipase promoter in 3T3-L1 adipocytes. J Clin Invest 1995, 95:1684-1689.
42. Gouni I, Oka K, Etienne J, Chan L: Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. J Lipid Res 1993, 34:139-146.
43. Hauner H, Petruschke T, Russ M, R-hrig K, Eckel J: Effects of tumour necrosis factor alpha (TNFα on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 1995, 38:764-771.
44. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
45. Spiegelman BM, Choy L, Hotamisligil GS, Graves RA, Tontonoz P: Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J Biol Chem 1993, 268:6823-6826.
46. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest 1995, 95:2409-2415.
47. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995, 95:2111-2119.
48. Soteriou A, Cryer A: Purification and characterization of lipoprotein lipase from the white adipose, skeletal muscle, cardiac muscle, mammary gland and lung tissues of the rat. Int J Biochem 1993, 25:1483-1490.
49. Soteriou A, Cryer A: Distinct immunoreactivities suggest the existence of potential tissue variants in rat lipoprotein lipase. Biochem J 1994, 299:417-423.
50. Yukht A, Davis RC, Ong JM, Ranganathan G, Kern PA: Regulation of lipoprotein lipase translation by epinephyrine in 3T3-L1 cells. Importance of the 3′ untranslated region. J Clin Invest 1995, 96:2438-2444.
51. Rangasathan G, Ong JM, Yukht A, Saghizadeh M, Simsolo RB, Pauer A, Kern PA: Tissue-specific expression of human lipoprotein lipase. J Biol Chem 1995, 270:7149-7155.
52. Gruen R, Hietanen E, Greenwood MRC: Increased adipose tissue LPL activity during the development of the genetically obese rat (fa/fa). Metab Clin Exp 1979, 27:1955-1966.
53. Greenwood MRC, Cleary MP, Steingrimsdottir L, Vassell JR: Adipose tissue metabolism and genetic obesity: the LPL hypothesis. Recent Adv Obesity Res 1981, 3:75-79.
54. Bessesen DH, Rupp CL, Eckel RH: Trafficking of dietary fat in lean rats. Obes Res 1995, 3:191-203.
55. Eckel RH: Llpoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. New Engl J Med 1989, 320:1060-1068.
56. +)-ATPase activity in liver and skeletal muscle are influenced by dietary fat type in rats. J Nutr 1995, 125:2364-1369.
57. Mauriege P, Marette A, Atgie C, Bouchard C, Theriault G, Bukowiecki LK, Marceau P, Biron S, Nadeau A, Despres JP: Regional variation in adipose tissue metabolism of severely obese premenopausal women. J Lipid Res 1995, 36:672-684.
58. Masuzaki H, Hosoda K, Ogawa Y, Shigemoto M, Satoh N, Mori K, Tamura N, Nishi S, Yoshimasa Y, Yamori Y, Nakao K: Augmented expression of obese (ob) gene during the process of obesity in genetically obese-hyperglycemic Wistar fatty (fa/fa) rats. FEBS Letters 1996, 378:267-271.
59. Shimomura I, Takahashi M, Tokunaga K, Keno Y, Nakamura T, Yamashita S, Takemura K, Yamamoto T, Funanasni T, Matsuzawa Y: Rapid enhancement of acyl-CoA synthetase, LPL, and GLUT-4 mRNAs in adipose tissue of VMH rats. Am J Physiol 1996, 270:995-1002.
60. Brun L-D, Gagne C, Juien P, Tremblay A, Moorjani S, Bouard C, Lupien P-J: Familial lipoprotein lipase-activity deficiency: study of total body fatness and subcutaneous fat tissue distribution. Metabolism 1989, 38:1005-1009.
61. Weinstock PH, Bisgaier CL, Aalto-Setäla K, Radner H, Ramakrishnan R, Levak-Frank S, Essenburg AD, Zechner R, Breslow JL: Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. J Clin Invest 1995, 96:2555-2568.
62. Coleman T, Seip RL, Gimble JM, Lee D, Maeda N, Semenkovich CF: COOH-disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J Biol Chem 1995. 270:12518-12525.
63. Wilson DE, Emi M, Iverius P-H, Hata A, Wu LL, Hillas E, Williams RR, Lalouel J-M: Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest 1990, 86:735-750.
64. Hellerstein MK, Christiansen M, Kaempfer S, Kletke C, Wu K, Reid JS, Mulligan K, Hellerstein NS, Shackleton CH: Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest 1991, 87:1841-1852.
65. Hudgins LC, Hellerstein M, Seidman C, Neese R, Diakun J, Hirsch J: Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest 1996, 97:2081-2091.
66. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB: Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 1993, 268:22243-22246.
67. Clarke SD, Jump DB: Regulation of gene transcription by polyunsaturated fatty acids. Prog Lipid Res 1993, 32:139-149.
68. Jump DB, Clarke SD, Thelen A, Liimatta M: Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. J Lipid Res 1994, 35:1076-1084.
69. Clarke SD, Jump DB: Polyunsaturated fatty acid regulation of hepatic gene transcription. Lipids 1996, 31(Suppl):S7-S11.
70. Cao Z, Umek RM, McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Gene Dev 1991, 5:1538-1552.
71. Yeh WC, Cao Z, Classon M, McKnight SL: Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Gene Dev 1995, 9:168-181.
72. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPARg2: tissue-specific regulator of an adipocyte enhancer. Cell 1994, 79:1147-1156.
73. Amri EZ, Boniro F, Ailhaud G, Abumrad NA, Grimaldi PA: Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem 1995, 270:2367-2371.
74. Tontonoz P, Kim JB, Graves RA, Spiegelman BM: ADD-1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 1993, 13: 4753-4759.
75. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS: SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993, 75:187-197.
76. Wang X, Sato R, Brown MS, Hua X, Goldstein JL: SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 1994, 77:53-62.
77. Lopez JM, Bennett MK, Sanchez HB, Rosenfeld JM, Osborne TF: Sterol regulation of acetyl Co-A Carboxylase: A mechanism for coordinate control of cellular lipid. Proc Natl Acad Sci U S A 1996, 93:1049-1053.
78. Bennett MK, Lopez JM, Sanchez HB, Osborne TF: Sterol regulation of fatty acid synthase promoter: Coordinate feedback regulation of two major lipid pathways. J Biol Chem 1995, 270:25578-25583.
79. Kim JB, Spiegelman BM: ADD-1/SREBP-1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Gene Dev 1996, 10:1096-1107.
80. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL: Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expression truncated SREBP-1a. J Clin Invest 1996, 98:1575-1584.
81. Schoonjans K, Peinado-Onsurbe J, Lefebvre A-M, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J: PPARa and PPARg activators direct a distinct tissue-specific transcriptional response via PPRE in the lipoprotein lipase gene. EMBO J 1996, 15:5336-5348.
82. Tan MH, Sata T, Havel RJ: The significance of lipoprotein lipase in rat skeletal muscles. J Lipid Res 1977, 18:363-370.
83. Ferraro RT, Eckel RH, Larson DE, Fontvieille A-M, Rising R, Jensen DR, Ravussin E: Relationship between skeletal muscle lipoprotein lipase activity and 24-hour macronutrient oxidaton. J Clin Invest 1993, 92:441-445.
84. van der Vusse GJ, Glatz JFC, Stam HCG, Reneman RS: Fatty acid homeostasis in the normoxic and ischemic heart. Physiological Reviews 1992, 72:881-940.
85. Linder C, Chernick SS, Fleck R, Scow RO: Lipoprotein lipase and uptake of chylomicron triglyceride by skeletal muscle of rats. Am J Physiol 1976, 231:860-864.
86. Levak-Frank S, Radner H, Walsh A, Stollberger R, Knipping G, Hoefler G, Sattler W, Weinstock PH, Breslow JL, Zechner R: Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J Clin Invest 1995, 96:976-986.
87. Fielding BA, Callow J, Owen RM, Samra JS, Matthews DR, Frayn KN: Postprandial lipemia: the origin of an early peak studied by specific dietary fatty acid intake during sequential meals. Am J Clin Nutr 1996, 6381:36-41.
88. Frayn KN, Coppack SW, Fielding BA, Humphreys SM: Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: implications for the control of fat storage and fat mobilization. Adv Enzyme Regul 1995, 35:163-178.
89. Gimble JM, Hua X, Wanker F, Morgan C, Robinson C, Hill MR, Nadon N: In vitro and in vivo analysis of murine lipoprotein lipase gene promoter: tissue-specific expression. Am J Physiol 1995, 268:E213-E218.
90. Storlien LH, Baur LA, Kriketos AD, Pan DA, Cooney GL, Jenkins AB, Calvert GD, Campbell LV: Dietary fats and insulin action. Diabetologia 1996, 39:621-631.
91. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963, 1:785-789
92. Randle PJ, Kerbey AL, Espinal J: Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. Diab Metab Reviewed 1988, 4:623-638.
93. Shimada M, Ishibashi S, Gotoda T, Kawamura M, Yamamoto K, Inaba T, Harada K, Ohsuga J, Perrey S, Yazaki Y: Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995, 15:1688-1694.
94. Khoo JC, Mahoney EM, Witztum JL: Secretion of lipoprotein lipase by macrophages in culture. J Biol Chem 1981, 256:7105-7108.
95. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Goldberg IJ, Steinberg D, Witztum JL: Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 1991, 88:10143-10147.
96. Mattsson L, Johansson H, Ottosson M, Bondjiers G, Wiklund O: Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta. J Clin Invest 1993, 92:1759-1765.
97. Evans AJ, Sawyez CG, Wolfe BM, Connelly PW, Maguire GF, Huff MW: Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms. J Lipid Res 1993, 34:703-717.
98. Renier G, Skamene E, DeSanctis JB, Radzioch D: High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. Arterioscler Thromb 1993, 13:190-196.
99. Renier G, Desfaits A-C, Lambert A, Mikhail R: Role of oxidant injury on macrophage lipoprotein lipase (LPL) production and sensitivity to LPL. J Lipid Res 1996, 37:799-809.
100. Mori N, Gotoda T, Ishibashi S, Shimano H, Harada K, Inaba T, Takaku F, Yazaki Y, Yamada N: Effects of human recombinant macrophage colony-stimulating factor on the secretion of lipoprotein lipase from macrophages. Arterioscler Thromb 1991, 11:1315-1321.
101. Inaba T, Kawamura M, Gotado T, Harada K, Shimada M, Ohsuga J-I, Shimano H, Akanuma Y, Yazaki Y, Yamada N: Effects of platelet-derived growth factor on the synthesis of lipoprotlen lipase in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 1995, 15:522-528.
102. Hendriks WL, van der Boom H, van Vark LC, Havekes LM: Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macropohages. Biochem J 1996, 314:563-568.
103. Panzenbyck U, Wintersberger A, Levak-Frank S, Zimmermann R, Zechner R, Kostner GM, Malle E, Sattler W: Implications of endogenous and exogenous lipoprotein lipase for the selective uptake of HDL-3 associated cholesterylesters by mouse peritoneal macrophages. J Lipid Res 1997, 38:239-253.
104. Sofer O, Fainaru M, Schafer Z, Goldman R: Regulation of lipoprotein lipase secretion in murine macrophages during foam cell formation in vitro. Effect of triglyceride-rich lipoproteins. Arterioscler Thromb 1992, 12:1458-1466.
105. Hulten LM, Lindmark H, Diezfalusy U, Björkhem I, Ottosson M, Liu Y, Bondjiers G, Wiklund O: Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J Clin Invest 1996, 97:461-468.
106. Hill MR, Kelly K, Wu X, Wanker F, Bass H, Morgan C, Wang C, Gimble JM: Lipopolysaccaride regulation of lipoprotein lipase expression in murine macrophages. Infect Immun 1995, 63:858-864.
107. Gardette J, Margelin D, Maziere JC, Bertrand J, Picard J: Effect of dibutyryl cyclic AMP and theophylline on lipoprotein lipase secretion by human monocyte-derived macrophages. FEBS Lett 1987, 225:178-182.
108. Friedman G, Chajek-Shaul T, Gallily R, Stein O, Shiloni E, Etienne J, Stein Y: Modulation of lipoprotein lipase activity in mouse peritoneal macrophages by recombinant human tumor necrosis factor. Biochim Biophys Acta 1988, 963:201-207.
109. Querfeld U, Ong JM, Prehn J, Carty J, Saffari B, Jordan SC, Kern PA: Effects of cytokines on the production of lipoprotein lipase in cultured human macrophages. J Lipid Res 1990, 31:1379-1386.
110. Domin WS, Chait A, Deeb SS: Transcriptional activation of the lipoprotein lipase gene in macrophages by dexamethasone. Biochemistry 1991, 30:2570-2574.
111. Desanctis JB, Varesio L, Radzioch D: Prostaglandins inhibit lipoprotein lipase gene expression in macrophages. Immunol 1994, 81:605-610.
112. Renier C, Skamene E, DeSanctis JB, Radzich D: Induction of tumor necrosis factor gene expression by lipoprotein lipase. J Lipid Res 1994, 35:271-278.
113. Renier G, Lambert A: Lipoprotein lipase synergizes with interferon gamma to induce macrophage nitric oxide synthetase mRNA expression and nitric oxide production. Arterioscler Thromb Vasc Biol 1995, 15:392-399.
114. Staels B, Martin G, Martinez M, Albert C, Peinado-Onsurbe J, Saladin R, Hum DW, Reina M, Vilaro S, Auwerx J: Expression and regulation of the lipoprotein lipase gene in human adrenal cortex. J Biol Chem 1996, 271:17425-17432.
115. Klingenspor M, Ebbinghaus C, H, Ishorst G, St-hr S, Spiegelhalter F, Haas K, Heldmaier G: Multiple regulation steps are involved in the control of lipoprotein lipase activity in brown adipose tissue. J Lipid Res 1996, 37:1685-1695.
116. Trayhurn P, Duncan JS, Rayner DV: Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem J 1995, 311:729-733.
117. Obregon MJ, Cannon B, Nedergaard J: Postnatal selective suppression of lipoprotein lipase gene expression in brown adipose tissue (relative to the expression of the gene for the uncoupling protein) is not due to adrenergic insensitivity: a possible specific inhibitory effect of colostrum. Biochem J 1996, 314:261-267.
118. Costelli P, Llovera M, Lopez-Soriano J, Carbo N, Tessitore L, Lopez-Soriano FJ, Baccino FM, Argiles JM: Lack of effect of eicosapentaenoic acid in preventing cancer cachexia and inhibiting tumor growth. Cancer Letters 1995, 97:25-32.
119. Cole SA, Hixon JE: Baboon lipoprotein lipase: cDNA sequence and variable tissue-specific expression of two transcripts. Gene 1995, 161:265-169.
120. Eckel RH, Robbins RJ: Lipoprotein lipase is produced, regulated and functional in rat brain. Proc Natl Acad Sci USA 1984, 81:7604-7607.
121. Nunez M, Peinado-Onsurbe J, Vilaro S, Llobera M: Lipoprotein lipase activity in developing rat brain areas. Biol Neonate 1995, 68:119-127.
122. Brecher P, Kuan HT: Lipoprotein lipase and acid lipase activity in rabbit brain microvessels. J Lipid Res 1979, 20:464-671.
123. Traber MG, Olivecrona T, Kayden HJ: Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro. J Clin Invest 1985, 75:1729-1734.
124. Friedman G, Chajek-Shaul T, Stein O, Olivecrona T, Stein Y: The role of lipoprotein lipase in the assimilation of cholesteryl ester by cultured cell incubated with labelled chylomicrons. Biochim Biophys Acta 1991, 666:156-164.
125. Brunzell JD: Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In The metabolic and molecular bases of inherited disease. Vol 11. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. McGraw-Hill; 1995:1913-1932.
126. St. Amand J, Moorjanit S, Lupien PJ, Prud'homme D, Despres JP: The relation of plasma triglyceride, apolipoprotein B, and high density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotein E polymorphism. Metabolism 1996, 45:261-267.
127. Miesenböck G, Hölzl B, Föger B, Brandstätter E, Paulweber B, Sandhofer F, Patsch JR: Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest 1993, 91:448-455.
128. Havel RJ: Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol 1994, 5:102-109.
129. Ebenbichler CF, Kirchmaier H, Egger C, Patsch JR: Postprandial state and atherosclerosis. Curr Opin Lipidol 1995, 6:286-290.
130. de Man FHAF, Castr Cabezas M, van Barlingen HHJJ, Erkelens DW, de Bruin TWA: Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post prandial metabolism and relation to premature atherosclerosis. Eur J Clin Invest 1996, 26:89-108.
131. Zilversmit DB: Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem 1995, 41:153-158.
132. Seed M, Mailly F, Vallance D, Doherty E, Winder A, Talmud P, Humphries SE: Lipoprotein lipase activity in patients with combined hyperlipidaemia. J Clin Invest 1994, 72:100-106.
133. Nevin DN, Brunzell JD, Deeb SS: The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler Thromb 1994, 14:869-873.
134. Benlian P, DeGennes JL, Foubert L, Zhang H, Gagne SE, Hayden M: Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 1996, 335:848-854.
135. Taskinen MR: Lipoprotein lipase in hypertriglyceridemias. In Lipoprotein lipase. Edited by Borensztajn J. Chicago: Evener; 1987:247-374.
136. Borensztajn J, Rone MS, Babirak SP, McGarr JA, Oscai LB: Effect of exercise on lipoprotein lipase activity in rat heart and skeletal muscle. Am J Physiol 1975, 229:394-397.
137. Ohrvall M, Lithell H, Johansson J, Vessby B: A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia. Metabolism 1995, 44:212-217.
138. Seip RL, Angelopoulos TJ, Semenkovich CF: Exercise induced human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue. Am J Physiol 1995, 268:E229-E236.
139. Ong JM, Simsolo RB, Saghizadeh M, Goers JW, Kern PA: Effects of exercise training and feeding on lipoprotein lipase gene expression in adipose tissue, heart, and skeletal muscle of the rat. Metabolism 1995, 44:1596-1605.
140. Botter JI, Bu X, Cantor RM, Warden CH, Brown J, Gray RJ, Blanche PJ, Krauss RM, Lusis AJ: Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am J Hum Genet 1996, 58:585-594.
141. Campos H, Dreon DM, Krauss RM: Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. J Lipid Res 1995, 36:462-472.
142. Jemaa R, Fumeron F, Poirier O, Lecerf L, Evans A, Arveiller D, Luc G, Cambou J-P, Bard J-M, Fruchard J-C et al.: Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res 1995, 36:2141-2146
143. Vohl MC, Lamarche B, Moorjani S, Prud'homme D, Nadeau A, Bouchard C, Lupien PJ, Despres JP: The lipoprotein lipase Hindill polymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscler. Thromb Vasc Biol 1995, 15:714-720.
144. Shimada M, Shimano H, Gotoda T, Yamamoto K, Kawamura M, Inaba T, Yazaki Y, Yamada N: Overexpression of human lipoprotein lipase in transgenic mice: resistance to diet induced hypertriglyceridemia and hypercholesterolemia. J Biol Chem 1993, 268:17924-17929.
145. Liu M.S, Jirik FR, LeBoeuf RC, Henderson H, Castellani LW, Lusis AJ, Ma Y, Forsythe IJ, Zhang H, Kirk E et al.: Alteration of lipid profiles in plasma of transgenic mice expressing human lipoprotein lipase. J Biol Chem 1994, 269:11417-11424.
146. Zsigmond E, Scheffler E, Forte TM, Potenz R, Wu W, Chan L: Transgenic mice expressing human lipoprotein lipase driven by the metallothionein promoter. J Biol Chem 1994, 269:18757-18766.
147. Mailly F, Tugrul Y, Reymer PWA, Bruin T, Seed M, Groenemeyer BF, Asplund-Carlson A, Vallance D, Winder AF, Miller GJ et al.: A common variant in the gene for lipoprotein lipase (Asp9 → Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 1995, 15:468-478.
148. Reymer PW, Gagne E, Groenemeyer BE, Zhang H, Forsyth I, Jansen H, Seidell JC, Kromhout D, Lie KE, Kastelein J: A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet 1995, 10:28-34.
149. Busca R, Peinado J, Vilella E, Auwerx J, Deeb SS, Vilaro S, Reina M: The mutant Asn291 → Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin. FEBS Lett 1995, 367:257-262.
150. Fisher RM, Mailly F, Peacock RE, Hamsten A, Seed M, Yudkin JS, Beisiegel U, Feussner G, Miller G, Humphries SE, Talmud PJ: Interaction of the lipoprotein lipase asparagine 291 → serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res 1995, 36:2104-2112.
151. Mailly F, Fisher RM, Nicaud V, Luong L-A, Evans AE, Marques-Vidal P, Luc G, Arveiler D, Band JM, Poirier O et al.: Association between the PL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study. Atherosclerosis 1996, 122:21-28.
152. Pimstone SN, Glee SM, Gagne SE, Miao L, Zhang H, Stein EA, Hayden MR: A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J Lipid Res 1996, 37:1675-1684.
153. Zhang H, Henderson H, Gagne SE, Clee SM, Miao L, Liu G, Hayden MR: Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1996, 302:159-166.
154. Hata A, Robertson M, Erni M, Lalouel JM: Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res 1990, 18:5407-5410.
155. Galton DJ, Mattu R, Needham EW, Cavanna J: Identification of mutative beneficial mutations for lipid transport. Z Gastroenterol 1996, 34(suppl. 3):56-58.
156. Nikkilä EA, Taskinen MR, Kekki M: Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man. Atherosclerosis 1978, 29:497-501.
157. Taskinen MR, Nikkilä EA: High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man - evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase. Clin Chim Acta 1981, 112: 325-332.
158. Kiens B, Lithell H: Lipoprotein metabolism influenced by training-induced changes in human skeletal muscle. J Clin Invest 1989, 83:558-565.
159. Sady SP, Cullinane EM, Saritelli A, Bernier D, Thompson PD: Elevated high-density lipoprotein cholesterol in endurance athletes is related to enhanced plasma triglyceride clearance. Metabolism 1988, 37:568-574.
160. Tikkanen HO, Näven H, Härönen M: Skeletal muscle fiber distribution influences serum high-density lipoprotein cholesterol level. Atherosclerosis 1996, 120:1-5.
161. Wolle J, Ferguson E, Devall LJ, Newton RS, Saxena U: Identification of a novel 85-kDa lipoprotein lipase binding protein on human aortic endothelial cell surface. Biochem Biophys Res Commun 1995, 216:906-912.
162. Tanuma Y, Nakabayashi H, Esumi M, Endo H: A silencer element for the lipoprotein lipase gene promoter and cognate double- and single-stranded DNA-binding proteins. Mol Cell Biol 1995, 15:517-123.
163. Saxena U, Auerbach BJ, Ferguson E, Wolle J, Marcel YL, Weisgraber KH, Hegele RA, Bisgaier CL: Apolipoprotein B and E basic amino acid clusters influence low-density lipoprotein association with lipoprotein lipase anchored to the subendothelial matrix. Arterioscler Thromb Vasc Biol 1995, 15:1240-1247.
164. Pang L, Sivaram P, Goldberg IJ: Cell-surface expression of an aminoterminal fragment of apolipoprotein B increases lipoprotein lipase binding to cells. J Biol Chem 1996, 271:19518-19523.
165. Sivaram P, Vanni-Reyes T, Goldberg IJ: Endothelial cells synthesize and process apolipoprotein B. J Biol Chem 1996, 271: 15261-15266.
166. Saxena U, Goldberg IJ: Endothelial cells and atherosclerosis: lipoprotein metabolism, matrix interactions, and monocyte recruitment. Curr Opin Lipidol 1994, 5:316-322.
167. Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T, Nakai T: Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem 1995, 270:15747-15754.
168. Argraves KM, Battey FD, MacCalman CD, McCrae KR, Gafvels M, Kozarsky KF, Chappell DA, Strauss JF III, Stickland DK: The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J Biol Chem 1995, 270:26550-26557.
169. Masuzaki H, Jingami H, Matsuoka N, Nakagawa O, Ogawa Y, Mizuno M, Yoshimasa Y, Yamamoto T, Nakao K: Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart. Circ Res 1996, 78:8-14.
170. Villeala E, Joven J, Fernandez M, Vilaro S, Brunzell JD, Olivecrona T, Olivecrona G: Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. J Lipid Res 1993, 34:1555-1562.
171. Choi SY, Sivaram P, Walker DE, Curtiss LK, Gretch DG, Sturley SL, Attie AD, Deckelbaum RJ, Goldberg IJ: Lipoprotein lipase association with lipoproteins involves protein-protein interaction with apolipoprotein B. J Biol Chem 1995, 270:8081-8086.
172. Carrera P, Gomez-Coronado D, Olivecrona G, Lasuncion MA: Binding of lipoprotein lipase to apolipoprotein B containing lipoproteins. Biochim Biophys Acta 1996, 1299:198-206.
173. Hultin M, Carneheim C, Rosenqvist K, Olivecrona T: Intravenous lipid emulsions: removal mechanisms as compared with chylomicrons. J Lipid Res 1995, 36:2174-2184.
174. Sattler W, Levak-Frank S, Radner H, Kostner GM, Zechner R: Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased alpha-tocopherol levels in skeletal muscle. Biochem J 1996, 318:15-19.